These final results, together with a former report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,two assistance the notion of concentrating on ACKR3 as a singular solution to modulate the opioid program, which could open up new therapeutic avenues